Skip to main content
. 2014 Jan 11;5(2):438–450. doi: 10.18632/oncotarget.1686

Table 4. Validated mutations in WGS retinoblastoma data.

Sample tierl1 tier2 tier3 Total Indels SVs CNV-AMP CNV-Mb-AMP CNV-DEL CNV-Mb-DEL Total-CNV-Mb
SJRB011 4(2) 12 72 88 0 24 6 72.52 7 146.24 218.77
SJRB014 0 2 23 25 0 11 3 218.39 6 5.42 223.82
SJRB016 0 0 2 2 0 1 0 0 0 0 0
SJRB020 0 6 45 51 0 3 5 136.31 2 243.93 380.25
SJRB024 3(0) 8 73 84 1 28 38 903.47 0 0 903.47
SJRB031 32(15) 59 467 558 0 74 100 2840.21 13 0.49 2840.70
SJRB032 12(5) 17 171 200 0 17 46 2787.49 0 0 2787.49
SJRB035 0 1 22 23 0 0 0 0 0 0 0
SJRB039 7(2) 12 94 113 0 96 48 227.68 75 117.54 345.23
SJRB051 2(1) 5 50 57 0 52 5 250.60 31 11.19 261.79
1

Tier 1 mutations include all mutations in genes including silent mutations and mutations in the 5′ and 3′ UTRs. The number of nonsynonymous mutations that alter the coding sequence are shown in parentheses.